Pandemic Acceptance and Commitment Therapy (Pan-ACT): Telehealth Delivery With Older Veterans
Pan-ACT
2 other identifiers
observational
24
1 country
1
Brief Summary
Older adults have been disproportionately impacted and distressed by the novel coronavirus (COVID-19) pandemic. Social distancing and stay-at-home orders have increased older adults' risk of social isolation and loneliness that will has led to a pandemic-induced fear of being in close proximity to other people. These fears and avoidant behaviors will have lasting effects if not treated with effective, safe, and convenient psychological interventions. This study will evaluate the acceptability and feasibility of delivering a small group intervention, called Acceptance and Commitment Therapy (ACT), through a telehealth modality to Veterans ages 60 and older who are experiencing pandemic-related emotional and physical distress. ACT helps decrease emotional suffering, improve well-being and promote positive behavior change by increasing one's psychological flexibility through the practice of mindfulness, acceptance, and values-based behaviors. The knowledge gained from this study will be used to better tailor the invention to meet the needs of older Veterans in an era of post-pandemic recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2022
CompletedFirst Posted
Study publicly available on registry
June 27, 2022
CompletedStudy Start
First participant enrolled
December 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 23, 2025
CompletedResults Posted
Study results publicly available
July 22, 2026
CompletedJuly 22, 2026
June 1, 2026
2 years
June 21, 2022
December 11, 2025
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Acceptability of Study Protocol - Retention
Retention is defined as number of participants who completed the post-treatment endpoint assessment (numerator) divided by the number of participants who signed informed consent (enrolled; denominator).
14 weeks
Feasibility of Study Protocol - Telehealth Capability
Percent of participants enrolled (i.e., signed consent) who have telehealth capability for duration of intervention.
14 weeks
Acceptability of Intervention - Group Attendance
Percent of participants who started the Pan-ACT intervention (denominator) and attended 70% or more of intervention sessions (numerator)
14 weeks
Other Outcomes (4)
Acceptability of Study Protocol - Enrollment
14 weeks
Acceptability of Study Protocol - Assessment Completion
14 weeks
Feasibility of Study Protocol - Timeline
Through study completion (approximately 2 years) last session at year 2 reported.
- +1 more other outcomes
Study Arms (1)
Pandemic Acceptance and Commitment Therapy (Pan-ACT)
Open label assignment to Pan-ACT group telehealth intervention.
Interventions
Pan-ACT is a 10-session, closed group, transdiagnostic intervention for older adults delivered by telehealth platform.
Eligibility Criteria
Veterans ages 60 and older receiving services at the Tuscaloosa VA Medical Center (TVAMC) were recruited from primary care, home-based primary care, and mental health clinics.
You may qualify if:
- Veteran
- receives care at Tuscaloosa VA Medical Center
- score of 9 or greater on the COVID-19 Mental Health Impacts Scale
- English speaking
- provides written informed consent
- age 60 or older
You may not qualify if:
- diagnosis of dementia
- score of 31 or less on the Modified Telephone Interview for Cognitive Status
- actively suicidal or homicidal
- actively psychotic
- unstable medical condition
- active substance use disorder
- currently participating in another cognitive behavioral therapy (CBT) intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tuscaloosa VA Medical Center, Tuscaloosa, AL
Tuscaloosa, Alabama, 35404-5015, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The study enrollment was negatively impacted by the timing of the study launch, i.e. study recruitment started in 2022 after the COVID-19 pandemic social restrictions had been lifted and pandemic-related fears had been reduced once a COVID-19 vaccine was universally available. This resulted in a small sample size which is a limitation of the trial. Homework adherence could not be collected, so is no longer included as an outcome of the study.
Results Point of Contact
- Title
- M. Lindsey Jacobs, PhD
- Organization
- University of Alabama
Study Officials
- PRINCIPAL INVESTIGATOR
Lori L Davis, MD
Tuscaloosa VA Medical Center, Tuscaloosa, AL
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2022
First Posted
June 27, 2022
Study Start
December 20, 2022
Primary Completion
December 31, 2024
Study Completion
January 23, 2025
Last Updated
July 22, 2026
Results First Posted
July 22, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share